The US Food and Drug Administration (FDA) has approved AbbVie’s supplemental new drug application, updating the indication ...

Evidence is growing that psychedelics could hold the key to managing inflammation, one of the body’s central drivers of many chronic diseases, including depression, arthritis and heart conditions.” By ...

A silent epidemic of chronic inflammation affects nearly half of adults worldwide. This condition is now linked to about 60 ...

Intracerebral hemorrhages (ICH) account for 15% of strokes but a disproportionate 50% of all stroke deaths. An ICH occurs ...

Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease Control and Prevention reports that it kills more than 52,000 people a year in the United ...

ABIVAX Société Anonyme's Obefazimod shows robust efficacy and differentiation in early Phase 3 trials. Click here to read why ...

A new study published in the journal eNeuro provides evidence that cannabidiol (CBD), a nonpsychoactive compound derived from ...

Facilitating earlier diagnosis and more precise treatment for patients with inflammatory diseases. This is the goal as the ...

Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose ...

Mitochondria isolated from onions entered lung immune cells in mice and restored their energy balance, revealing an ...

Researchers have identified a rare type of brain cell that may drive the chronic inflammation and neurodegeneration seen in progressive multiple sclerosis (MS).

Hand swelling, or oedema, can stem from various causes including heat, high salt intake, exercise, and pregnancy. Underlying ...